UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 27, 2024, the Board of Directors of Fortune Brands Innovations, Inc. (the “Company”) appointed Karen Ries to serve as Senior Vice President and Chief Accounting Officer and the Company’s principal accounting officer, effective March 1, 2024.
Ms. Ries, age 41, has served as Vice President and Global Controller of the Company since August 2023. Prior to joining the Company, she served as Vice President and Controller of Univar Solutions, a distributor of chemistry and related products and services, from September 2021 to August 2023. From May 2018 through September 2021, she served as Assistant Controller of AbbVie, Inc, a biopharmaceutical company.
There are no family relationships between Ms. Ries and any director or executive officer of the Company and there are no transactions involving the Company that would be required to report pursuant to Item 404(a) of Regulation S-K.
Ms. Ries participates in the Company’s executive compensation program, which includes base salary, an annual incentive bonus and annual long-term incentive awards in the form of performance share awards, restricted stock unit awards and stock options. Ms. Ries’ 2024 annual long-term annual incentive award value was set considering market data for a chief accounting officer role.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
FORTUNE BRANDS INNOVATIONS, INC. |
|
|
|
|
Date: |
March 1, 2024 |
By: |
/s/ Hiranda S. Donoghue |
|
|
|
Hiranda S. Donoghue |